Pharming Group N.V (PHAR) Cash from Financing Activities: 2020-2022
Historic Cash from Financing Activities for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2022 value amounting to -$2.9 million.
- Pharming Group N.V's Cash from Financing Activities fell 21.39% to -$2.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$2.9 million, marking a year-over-year decrease of 20.21%. This contributed to the annual value of -$27,884 for FY2021, which is 100.05% down from last year.
- Per Pharming Group N.V's latest filing, its Cash from Financing Activities stood at -$2.9 million for Q4 2022, which was down 186.63% from $3.3 million recorded in Q3 2022.
- In the past 5 years, Pharming Group N.V's Cash from Financing Activities ranged from a high of $25.0 million in Q3 2021 and a low of -$25.0 million during Q2 2021.
- In the last 3 years, Pharming Group N.V's Cash from Financing Activities had a median value of -$1.3 million in 2020 and averaged -$605,137.
- In the last 5 years, Pharming Group N.V's Cash from Financing Activities soared by 1,285.00% in 2021 and then tumbled by 121,286.55% in 2022.
- Quarterly analysis of 3 years shows Pharming Group N.V's Cash from Financing Activities stood at $1.4 million in 2020, then tumbled by 275.13% to -$2.4 million in 2021, then declined by 21.39% to -$2.9 million in 2022.
- Its Cash from Financing Activities stands at -$2.9 million for Q4 2022, versus $3.3 million for Q3 2022 and -$451,000 for Q2 2022.